4//SEC Filing
Priour James 4
Accession 0000899243-21-015672
CIK 0001403752other
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 9:30 PM ET
Size
9.8 KB
Accession
0000899243-21-015672
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Priour James
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Shares
2021-04-13+2,266→ 2,953 total - Exercise/Conversion
Restricted Stock Unit
2021-04-13−2,266→ 4,534 total→ Common Shares (2,266 underlying) - Sale
Common Shares
2021-04-13$27.93/sh−950$26,533→ 2,003 total
Footnotes (5)
- [F1]Represents common shares issued upon vesting of one third of the restricted stock units ("RSUs") granted on April 13, 2020.
- [F2]Represents common shares sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs. Pursuant to the terms of the applicable RSU grant agreement (the "Grant Agreement"), effective on the grant date of the RSUs, the Reporting Person irrevocably adopted a 10b5-1 plan pursuant to which the Reporting Person elected to sell shares to cover tax withholding obligations and other applicable fees in accordance with the terms of the Grant Agreement.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.92 to $27.96, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F4]Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F5]The RSUs were granted on April 13, 2020 and vest in three equal annual instalments beginning on April 13, 2021.
Documents
Issuer
Zymeworks Inc.
CIK 0001403752
Entity typeother
Related Parties
1- filerCIK 0001843630
Filing Metadata
- Form type
- 4
- Filed
- Apr 12, 8:00 PM ET
- Accepted
- Apr 13, 9:30 PM ET
- Size
- 9.8 KB